Q1 2025 Holdings
Filed 2025-05-14 | 66 holdings | $102.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $13.6M | 48,000 | 13.3% |
| Evolus Inc(EOLS) | COM | 30052C107 | $13.6M | 1,134,574 | 13.3% |
| Optinose Inc(0OP) | COM NEW | 68404V209 | $7.2M | 788,647 | 7.0% |
| Zevra Therapeutics Inc(ZVRA) | COM NEW | 488445206 | $4.9M | 650,000 | 4.7% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $3.7M | 613,000 | 3.6% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $3.7M | 333,400 | 3.6% |
| Surrozen Inc(SRZN) | COM NEW | 86889P208 | $3.3M | 285,782 | 3.2% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $3.3M | 590,742 | 3.2% |
| Anika Therapeutics Inc(ANIK) | COM | 035255108 | $3.3M | 206,639 | 3.2% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $3.0M | 200,000 | 3.0% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $3.0M | 74,500 | 3.0% |
| Indivior PLC(INDV) | ORD | G4766E116 | $2.9M | 304,000 | 2.8% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $2.8M | 527,842 | 2.7% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $2.8M | 348,820 | 2.7% |
| Xoma Royalty Corporation(XOMA) | COM NEW | 98419J206 | $2.6M | 129,813 | 2.5% |
| Tela BIO Inc(TELA) | COM | 872381108 | $2.5M | 2,055,225 | 2.4% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $2.4M | 93,968 | 2.3% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $2.0M | 914,973 | 1.9% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $1.8M | 796,100 | 1.7% |
| Edesa Biotech Inc(EDSA) | COM NEW | 27966L306 | $1.7M | 687,500 | 1.6% |
| Myomo Inc(MYO) | COM NEW | 62857J201 | $1.3M | 276,707 | 1.3% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $1.0M | 100,000 | 1.0% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $937.2K | 144,628 | 0.9% |
| Scpharmaceuticals Inc(SCPH) | COM | 810648105 | $914.4K | 347,687 | 0.9% |
| Inovio Pharmaceuticals Inc(INO) | COM SHS | 45773H409 | $844.9K | 518,331 | 0.8% |
| Profound Medical Corp(PROF) | COM NEW | 74319B502 | $814.5K | 139,942 | 0.8% |
| Geron Corp(GERN) | COM | 374163103 | $795.0K | 500,000 | 0.8% |
| Aytu Biopharma Inc(AYTU) | COM | 054754858 | $795.0K | 463,721 | 0.8% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $738.4K | 212,783 | 0.7% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $686.9K | 630,183 | 0.7% |
| Grace Therapeutics Inc(GRCE) | COM | 00439U104 | $665.7K | 294,550 | 0.6% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $656.7K | 110,000 | 0.6% |
| Calcimedica Inc(CALC) | COM NEW | 38942Q202 | $615.1K | 367,371 | 0.6% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $615.1K | 20,607 | 0.6% |
| Kiora Pharmaceuticals Inc(KPRX) | COM | 49721T507 | $603.9K | 200,647 | 0.6% |
| Y-Mabs Therapeutics Inc(YMABUSD) | COM | 984241109 | $581.0K | 131,160 | 0.6% |
| Xeris Biopharma Holdings Inc(XERS) | COM | 98422E103 | $561.4K | 102,265 | 0.5% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $500.8K | 620,588 | 0.5% |
| Kezar Life Sciences Inc(KZR) | COM NEW | 49372L209 | $488.0K | 100,000 | 0.5% |
| Acelyrin Inc | COM | 00445A100 | $413.9K | 167,580 | 0.4% |
| I MAB(NBP) | SPONSORED ADS | 44975P103 | $398.5K | 483,647 | 0.4% |
| Septerna Inc(SEPN) | COM | 81734D104 | $394.2K | 68,084 | 0.4% |
| Hillevax Inc | COM | 43157M102 | $346.5K | 238,950 | 0.3% |
| Exagen Inc(XGN) | COM | 30068X103 | $343.7K | 95,747 | 0.3% |
| Renovorx Inc(RNXT) | COM NEW | 75989R107 | $275.4K | 278,188 | 0.3% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $248.7K | 21,550 | 0.2% |
| Cargo Therapeutics Inc(CRGX) | COM | 14179K101 | $203.5K | 50,000 | 0.2% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $203.5K | 508,266 | 0.2% |
| Milestone Pharmaceuticals in(MIST) | COM | 59935V107 | $200.0K | 250,000 | 0.2% |
| Bioage Labs Inc(BIOA) | COM | 09077V100 | $188.0K | 50,000 | 0.2% |